PRJNA793810
Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors
Genomic DNA from Fsmo;GFAP-cre mice treated with LDE225 or vehicle were isolated from tail (normal control) and medulloblastoma to identify treatment induced mutations in resistant tumors. Also, methyl-seq data from 10 samples.